Alkem Laboratories Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Alkem Laboratories Ltd. on BSE

Search Inside the pdf :

Alkem Laboratories Ltd.

23 Apr 2025

5033.00

0.19%

Company Update

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Updates on Acquisition

BSE India

In continuation of our earlier intimations dated 07th February, 2025 and 28th March, 2025, we wish to inform you that today i.e. 23rd April, 2025, the acquisition of Adroit by the Company stands completed in accordance with the conditions prescribed in the share purchase agreement dated 28th March, 2025 and accordingly, Adroit will now be a wholly owned subsidiary of the Company. Kindly take the same on record.

pdf

Alkem Laboratories Ltd.

16 Apr 2025

5033.00

0.19%

Company Update

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Updates on Acquisition

BSE India

In continuation of our earlier intimations dated 07th February, 2025 and 15th March, 2025, we wish to inform you that today i.e. 16th April, 2025, the acquisition of Bombay Ortho by Alkem Medtech stands completed in accordance with the conditions prescribed in the share purchase and share subscription agreement dated 15th March, 2025 and accordingly, Bombay Ortho will now be a wholly owned step-down subsidiary of the Company. Kindly take the same on record.

pdf

Alkem Laboratories Ltd.

31 Mar 2025

5033.00

0.19%

Company Update

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Change in Management

BSE India

This is to inform you that Mr. Adil Billimoria, Senior Management Personnel of the Company shall retire from the Company with effect from closing of business hours of 31st March, 2025.

pdf

Alkem Laboratories Ltd.

28 Mar 2025

5033.00

0.19%

Company Update

Alkem Laboratories Ltd - 539523 - Announcement Under Regulation 30 Of SEBI LODR- Regulatory Order

BSE India

Pursuant to Regulation 30 of SEBI LODR Regulations, 2015, this is to inform you that the Company has received orders passed by the statutory authority under the Goods and Services Tax Act, 2017. The relevant disclosure is enclosed herewith.

pdf

Alkem Laboratories Ltd.

28 Mar 2025

5033.00

0.19%

Company Update

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Updates on Acquisition

BSE India

In continuation of our earlier intimation dated 07th February, 2025, we wish to inform you that today i.e. 28th March, 2025, a share purchase agreement has been executed, inter alios, amongst the Company and Adroit.

pdf

Alkem Laboratories Ltd.

25 Mar 2025

5033.00

0.19%

SAST

Alkem Laboratories Ltd - 539523 - Disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011

BSE India

The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Madhurima Singh

pdf

Alkem Laboratories Ltd.

24 Mar 2025

5033.00

0.19%

SAST

Alkem Laboratories Ltd - 539523 - Closure of Trading Window

BSE India

This is to inform you that the trading window will remain closed from 30th March, 2025 until the expiry of 48 hours after the date on which the financial results of the Company for quarter and year ended 31st March, 2025 are communicated to the Stock Exchanges.

pdf

Alkem Laboratories Ltd.

20 Mar 2025

5033.00

0.19%

Company Update

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

Please find enclosed herewith the details of investor meeting scheduled to be held on 28th March, 2025.

pdf

Alkem Laboratories Ltd.

19 Mar 2025

5033.00

0.19%

Investor Presentation

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Please find enclosed herewith the presentation with respect to the Investor / Analyst Meeting scheduled to be held at ''HSBC Global Investment Summit 2025'' on 24th March, 2025 and 25th March, 2025 at Hong Kong.

pdf